Search

everythinglearnresearchcommunity

for

Search:↓

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

SLHA can be hard to diagnose and needs teamwork between specialists.

Treating H. pylori infection might help cure alopecia areata.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Prurigo pigmentosa mainly affects middle-aged White and Asian women, often linked to a ketogenic diet, and is best treated with oral antibiotics.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

More precise, personalized therapies are needed for autoimmune diseases.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Black and Hispanic women are more likely to have alopecia areata than white women.

MicroRNA-21 could help diagnose and treat skin fibrosis.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.